Safety of SARS-CoV-2 mRNA vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases

[1]  T. Nanki,et al.  Influence of immunosuppressive therapy on longitudinal changes in anti-SARS-CoV-2 spike protein antibodies after two doses of mRNA vaccines in patients with rheumatic diseases , 2023, European Journal of Internal Medicine.

[2]  J. J. Ríos-Blanco,et al.  Influence of vaccination and immunosuppressive treatments on the coronavirus disease 2019 outcomes in patients with systemic autoimmune diseases , 2022, European Journal of Internal Medicine.

[3]  A. Iagnocco,et al.  EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update , 2022, Annals of the Rheumatic Diseases.

[4]  X. Mariette,et al.  Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry , 2021, Annals of the Rheumatic Diseases.

[5]  E. Zavala-Flores,et al.  Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus , 2021, Clinical Rheumatology.

[6]  J. Singh,et al.  Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey , 2021, RMD Open.

[7]  D. Segev,et al.  Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two‐Dose SARS–CoV‐2 Messenger RNA Vaccination , 2021, Arthritis & rheumatology.

[8]  Andrew T. Kroger,et al.  American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2 , 2021, Arthritis & rheumatology.

[9]  G. Shefer,et al.  Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study , 2021, Annals of the Rheumatic Diseases.

[10]  J. Gottenberg,et al.  Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases , 2021, The Lancet Rheumatology.